RTSL (Rapid Therapeutic Science Laboratories) Ending Cash Position: $0.00 Mil (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Rapid Therapeutic Science Laboratories Ending Cash Position?

Rapid Therapeutic Science Laboratories RTSL Ending Cash Position is $0.00 Mil as of Jun. 2023.

Rapid Therapeutic Science Laboratories's Ending Cash Position for the quarter that ended in Jun. 2023 was $0.00 Mil.

Rapid Therapeutic Science Laboratories's quarterly Ending Cash Position increased from Dec. 2022 ($0.00 Mil) to Mar. 2023 ($0.02 Mil) but then declined from Mar. 2023 ($0.02 Mil) to Jun. 2023 ($0.00 Mil).

Rapid Therapeutic Science Laboratories's annual Ending Cash Position increased from Mar. 2020 ($0.14 Mil) to Dec. 2021 ($0.19 Mil) but then declined from Dec. 2021 ($0.19 Mil) to Dec. 2022 ($0.00 Mil).

Rapid Therapeutic Science Laboratories Ending Cash Position Related Terms

Rapid Therapeutic Science Laboratories Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Rapid Therapeutic Science Laboratories's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rapid Therapeutic Science Laboratories Ending Cash Position Chart

Rapid Therapeutic Science Laboratories Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Dec21 Dec22
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.00 0.14 0.19 0.00

Rapid Therapeutic Science Laboratories Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.00 0.00 0.02 0.00

Rapid Therapeutic Science Laboratories Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Rapid Therapeutic Science Laboratories's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.193+-0.193
=0.00

Rapid Therapeutic Science Laboratories's Ending Cash Position for the quarter that ended in Jun. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.017+-0.015
=0.00

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $0.00 Mil mean?
Rapid Therapeutic Science Laboratories (RTSL) has a Ending Cash Position of $0.00 Mil as of Jun. 2023. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Rapid Therapeutic Science Laboratories and its competitors.
Is Rapid Therapeutic Science Laboratories' Ending Cash Position too high?
Rapid Therapeutic Science Laboratories' current Ending Cash Position is $0.00 Mil.
How does Rapid Therapeutic Science Laboratories' Ending Cash Position compare to VRAYQ and NNMX?
Rapid Therapeutic Science Laboratories' Ending Cash Position of $0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Diversified Financial Services company?
A good Ending Cash Position depends on the Diversified Financial Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Rapid Therapeutic Science Laboratories and its competitors. Rapid Therapeutic Science Laboratories's current Ending Cash Position is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rapid Therapeutic Science Laboratories stock overvalued right now?
Rapid Therapeutic Science Laboratories (RTSL) has a current Ending Cash Position of $0.00 Mil. The current Ending Cash Position is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Rapid Therapeutic Science Laboratories (RTSL), the current Ending Cash Position is $0.00 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rapid Therapeutic Science Laboratories Business Description

Address 558 County Road 472, De Leon, TX, USA, 76444
Rapid Therapeutic Science Laboratories Inc currently has no operations and operates as a blank check company.